• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表位作图的现状与 COVID-19 中的机遇

State of the art in epitope mapping and opportunities in COVID-19.

作者信息

Hamed Samira M, Sakr Masarra M, El-Housseiny Ghadir S, Wasfi Reham, Aboshanab Khaled M

机构信息

Department of Microbiology & Immunology, Faculty of Pharmacy, October University for Modern Sciences & Arts (MSA), Giza, 12451, Egypt.

Department of Microbiology & Immunology, Faculty of Pharmacy, Ain Shams University, Cairo, 11566, Egypt.

出版信息

Future Sci OA. 2023 Feb;16(3-06):FSO832. doi: 10.2144/fsoa-2022-0048. Epub 2023 Mar 6.

DOI:10.2144/fsoa-2022-0048
PMID:36897962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9987558/
Abstract

The understanding of any disease calls for studying specific biological structures called epitopes. One important tool recently drawing attention and proving efficiency in both diagnosis and vaccine development is epitope mapping. Several techniques have been developed with the urge to provide precise epitope mapping for use in designing sensitive diagnostic tools and developing rpitope-based vaccines (EBVs) as well as therapeutics. In this review, we will discuss the state of the art in epitope mapping with a special emphasis on accomplishments and opportunities in combating COVID-19. These comprise SARS-CoV-2 variant analysis versus the currently available immune-based diagnostic tools and vaccines, immunological profile-based patient stratification, and finally, exploring novel epitope targets for potential prophylactic, therapeutic or diagnostic agents for COVID-19.

摘要

对任何疾病的理解都需要研究称为表位的特定生物结构。表位作图是一种最近引起关注并在诊断和疫苗开发中都证明有效的重要工具。为了提供精确的表位作图以用于设计灵敏的诊断工具、开发基于表位的疫苗(EBV)以及治疗方法,已经开发了几种技术。在这篇综述中,我们将讨论表位作图的最新进展,特别强调在抗击 COVID-19 方面的成就和机遇。这些包括 SARS-CoV-2 变体分析与当前可用的基于免疫的诊断工具和疫苗、基于免疫特征的患者分层,以及最后探索 COVID-19 潜在预防、治疗或诊断剂的新型表位靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e283/10051068/9bb58ff0f3c3/fsoa-09-832-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e283/10051068/9b52b533a54e/fsoa-09-832-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e283/10051068/86ae4e272882/fsoa-09-832-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e283/10051068/9bb58ff0f3c3/fsoa-09-832-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e283/10051068/9b52b533a54e/fsoa-09-832-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e283/10051068/86ae4e272882/fsoa-09-832-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e283/10051068/9bb58ff0f3c3/fsoa-09-832-g3.jpg

相似文献

1
State of the art in epitope mapping and opportunities in COVID-19.表位作图的现状与 COVID-19 中的机遇
Future Sci OA. 2023 Feb;16(3-06):FSO832. doi: 10.2144/fsoa-2022-0048. Epub 2023 Mar 6.
2
A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach.一种基于蛋白质组学的免疫信息学工具,用于加速新兴传染病背景下的 T 细胞表位发现和疫苗设计:一种面向种族的方法。
Front Immunol. 2021 Feb 26;12:598778. doi: 10.3389/fimmu.2021.598778. eCollection 2021.
3
Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.免疫信息学对抗 COVID-19/SARS-COV-2:预测疫苗的潜在 T 细胞表位。
Infect Disord Drug Targets. 2021;21(4):541-552. doi: 10.2174/1871526520666200921154149.
4
Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins.SARS-CoV-2 结构蛋白中潜在表位的免疫信息学作图。
PLoS One. 2021 Nov 15;16(11):e0258645. doi: 10.1371/journal.pone.0258645. eCollection 2021.
5
A Web-Based Platform on Coronavirus Disease-19 to Maintain Predicted Diagnostic, Drug, and Vaccine Candidates.基于网络的新型冠状病毒肺炎平台,用于维护预测的诊断、药物和疫苗候选物。
Monoclon Antib Immunodiagn Immunother. 2020 Dec;39(6):204-216. doi: 10.1089/mab.2020.0035. Epub 2020 Oct 30.
6
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.新型冠状病毒刺突蛋白受体结合域线性表位在 COVID-19 mRNA 疫苗接种者中的高分辨率线性表位作图。
Microbiol Spectr. 2021 Dec 22;9(3):e0096521. doi: 10.1128/Spectrum.00965-21. Epub 2021 Nov 10.
7
Severe Acute Respiratory Syndrome Coronavirus 2 Epitope Mapping for Antibodies.严重急性呼吸综合征冠状病毒 2 表位作图用于抗体。
Immunohorizons. 2022 Jun 13;6(6):344-355. doi: 10.4049/immunohorizons.2200030.
8
Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus.基于免疫信息学的新型 COVID-19 病毒 B 细胞和 T 细胞表位的肽疫苗设计。
Vaccine. 2021 Feb 12;39(7):1087-1095. doi: 10.1016/j.vaccine.2021.01.011. Epub 2021 Jan 9.
9
Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach.设计针对 SARS-CoV-2 的多表位疫苗:一种免疫信息学方法。
J Biomol Struct Dyn. 2022 Jan;40(1):14-30. doi: 10.1080/07391102.2020.1792347. Epub 2020 Jul 17.
10
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.

引用本文的文献

1
SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development.严重急性呼吸综合征冠状病毒2的进化:对诊断、治疗、疫苗有效性及研发的影响
Vaccines (Basel). 2024 Dec 28;13(1):17. doi: 10.3390/vaccines13010017.
2
Monitoring the VDPV2 outbreak in Egypt during 2020-2021 highlights the crucial role of environmental surveillance and boosting immunization in combating Poliovirus.监测埃及 2020-2021 年 VDPV2 疫情凸显了环境监测和加强免疫在抗击脊灰病毒方面的关键作用。
BMC Infect Dis. 2024 Aug 26;24(1):866. doi: 10.1186/s12879-024-09731-0.
3
Chimeric lipoproteins for leptospirosis vaccine: immunogenicity and protective potential.

本文引用的文献

1
Predicted B Cell Epitopes Highlight the Potential for COVID-19 to Drive Self-Reactive Immunity.预测的B细胞表位凸显了新冠病毒引发自身反应性免疫的可能性。
Front Bioinform. 2021 Aug 19;1:709533. doi: 10.3389/fbinf.2021.709533. eCollection 2021.
2
Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses.新型沙贝病毒双特异性中和抗体,对目前流行的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体和沙贝病毒具有卓越的广度和效力。
Cell Discov. 2022 Apr 21;8(1):36. doi: 10.1038/s41421-022-00401-6.
3
Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants.
用于钩端螺旋体病疫苗的嵌合脂蛋白:免疫原性和保护潜力。
Appl Microbiol Biotechnol. 2024 Jul 22;108(1):424. doi: 10.1007/s00253-024-13196-1.
4
Technical pitfalls when collecting, cryopreserving, thawing, and stimulating human T-cells.收集、冷冻保存、解冻和刺激人 T 细胞时的技术陷阱。
Front Immunol. 2024 May 15;15:1382192. doi: 10.3389/fimmu.2024.1382192. eCollection 2024.
5
Natural Antibodies Produced in Vaccinated Patients and COVID-19 Convalescents Recognize and Hydrolyze Oligopeptides Corresponding to the S-Protein of SARS-CoV-2.接种疫苗的患者和新冠康复者体内产生的天然抗体可识别并水解与新冠病毒S蛋白相对应的寡肽。
Vaccines (Basel). 2023 Sep 15;11(9):1494. doi: 10.3390/vaccines11091494.
6
Identification of Antibody-Mediated Hydrolysis Sites of Oligopeptides Corresponding to the SARS-CoV-2 S-Protein by MALDI-TOF Mass Spectrometry.通过 MALDI-TOF 质谱法鉴定与 SARS-CoV-2 S 蛋白对应的寡肽的抗体介导的水解位点。
Int J Mol Sci. 2023 Sep 20;24(18):14342. doi: 10.3390/ijms241814342.
7
Reverse Vaccinology and Immunoinformatic Approach for Designing a Bivalent Vaccine Candidate Against Hepatitis A and Hepatitis B Viruses.反向疫苗学和免疫信息学方法设计用于预防甲型和乙型肝炎病毒的双价疫苗候选物。
Mol Biotechnol. 2024 Sep;66(9):2362-2380. doi: 10.1007/s12033-023-00867-z. Epub 2023 Sep 16.
8
BBIBP-CorV Vaccination against the SARS-CoV-2 Virus Affects the Gut Microbiome.接种BBIBP-CorV新冠疫苗会影响肠道微生物群。
Vaccines (Basel). 2023 May 4;11(5):942. doi: 10.3390/vaccines11050942.
分离具有广谱中和活性的人源单克隆抗体,针对包括奥密克戎变异株在内的多种 SARS-CoV-2 病毒。
Antiviral Res. 2022 May;201:105297. doi: 10.1016/j.antiviral.2022.105297. Epub 2022 Mar 24.
4
Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice Models.开发针对 COVID-19 的有效基于肽的疫苗:在小鼠模型中的初步研究。
Viruses. 2022 Feb 22;14(3):449. doi: 10.3390/v14030449.
5
Neutralization or enhancement of SARS-CoV-2 infection by a monoclonal antibody targeting a specific epitope in the spike receptor-binding domain.针对刺突受体结合域中特定表位的单克隆抗体对 SARS-CoV-2 感染的中和或增强作用。
Antiviral Res. 2022 Apr;200:105290. doi: 10.1016/j.antiviral.2022.105290. Epub 2022 Mar 13.
6
RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants.RBD三聚体mRNA疫苗引发针对SARS-CoV-2变体的广泛且具有保护性的免疫反应。
iScience. 2022 Apr 15;25(4):104043. doi: 10.1016/j.isci.2022.104043. Epub 2022 Mar 11.
7
Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons.冠状病毒耐药性数据库 (CoV-RDB):SARS-CoV-2 对单克隆抗体、恢复期血浆和接种者血浆的敏感性。
PLoS One. 2022 Mar 9;17(3):e0261045. doi: 10.1371/journal.pone.0261045. eCollection 2022.
8
Rapid Biosensor of SARS-CoV-2 Using Specific Monoclonal Antibodies Recognizing Conserved Nucleocapsid Protein Epitopes.使用识别保守核衣壳蛋白表位的特异性单克隆抗体的新型冠状病毒快速生物传感器
Viruses. 2022 Jan 27;14(2):255. doi: 10.3390/v14020255.
9
Machine Learning Techniques for the Prediction of B-Cell and T-Cell Epitopes as Potential Vaccine Targets with a Specific Focus on SARS-CoV-2 Pathogen: A Review.用于预测作为潜在疫苗靶点的B细胞和T细胞表位的机器学习技术,特别关注SARS-CoV-2病原体:综述
Pathogens. 2022 Jan 24;11(2):146. doi: 10.3390/pathogens11020146.
10
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.大多数但并非所有个体对新冠病毒奥密克戎变种的T细胞反应性得以保留。
Cell. 2022 Mar 17;185(6):1041-1051.e6. doi: 10.1016/j.cell.2022.01.029. Epub 2022 Feb 3.